Aveanna Healthcare (NASDAQ:AVAH) Major Shareholder J.H. Whitney Equity Partners V Sells 2,250,000 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 2,250,000 shares of Aveanna Healthcare stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $11.50, for a total value of $25,875,000.00. Following the sale, the insider directly owned 12,315,892 shares in the company, valued at $141,632,758. This trade represents a 15.45% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Thursday, August 20th, J.H. Whitney Equity Partners V sold 12,496,077 shares of Aveanna Healthcare stock. The stock was sold at an average price of $11.50, for a total value of $143,704,885.50.
• On Tuesday, June 30th, J.H. Whitney Equity Partners V sold 2,419,035 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.01, for a total transaction of $19,376,470.35.
• On Wednesday, June 24th, J.H. Whitney Equity Partners V sold 919,389 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.00, for a total transaction of $7,355,112.00.
• On Wednesday, June 3rd, J.H. Whitney Equity Partners V sold 5,842,240 shares of Aveanna Healthcare stock. The stock was sold at an average price of $6.24, for a total transaction of $36,455,577.60.

Aveanna Healthcare Stock Performance

AVAH opened at $13.70 on Tuesday. The stock has a market capitalization of $2.99 billion, a price-to-earnings ratio of 11.14, a PEG ratio of 0.92 and a beta of 1.90. The company has a fifty day moving average of $9.71 and a 200 day moving average of $7.95. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $5.93 and a fifty-two week high of $13.98. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million for the quarter, compared to analysts’ expectations of $638.61 million. As a group, sell-side analysts forecast that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current fiscal year.

Key Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target from $10 to $16 and upgraded its rating to “outperform,” implying additional upside from the stock’s recent trading level. Benzinga analyst coverage
• Positive Sentiment: Truist Financial lifted its price target from $11 to $15 while maintaining a “hold” rating. The higher target reflects improved valuation expectations, even though Truist remains cautious on the shares. Benzinga analyst coverage
• Negative Sentiment: Insiders and major shareholders disclosed approximately 48.6 million shares of sales at an average price of $11.50, worth roughly $558.5 million. Sellers included Paul R. Vigano, Robert M. Williams Jr., and J.H. Whitney Equity Partners V, as well as CEO Jeff Shaner, director Rodney D. Windley, and insider Edwin C. Reisz. Although the sellers retained sizable positions, the volume of stock coming to market may pressure AVAH and raise questions about shareholder confidence. SEC insider transaction filing

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in Aveanna Healthcare by 38.0% during the fourth quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after acquiring an additional 1,535,351 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Aveanna Healthcare by 49.5% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock worth $8,593,000 after purchasing an additional 441,707 shares during the period. Segall Bryant & Hamill LLC boosted its stake in shares of Aveanna Healthcare by 425.8% during the 1st quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock worth $1,056,000 after purchasing an additional 132,779 shares during the period. NFJ Investment Group LLC bought a new position in Aveanna Healthcare during the 2nd quarter valued at about $2,682,000. Finally, Weiss Asset Management LP bought a new position in Aveanna Healthcare during the 1st quarter valued at about $732,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have recently issued reports on AVAH shares. Royal Bank Of Canada upped their price objective on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a report on Monday. Truist Financial raised their target price on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a report on Monday. Weiss Ratings restated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. Wall Street Zen downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 15th. Finally, Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $10.00 to $11.00 in a research report on Friday, May 15th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Aveanna Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $12.89.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.